Optimizing hypertension management in clinical practice

被引:7
作者
Heagerty, A. [1 ]
机构
[1] Univ Manchester, Div Cardiovasc & Endocrine Sci, Cardiovasc Res Grp, Manchester M13 9NT, Lancs, England
关键词
antihypertensives; angiotensin receptor blockers; thiazide diuretics; angiotensin-converting enzyme inhibitors; beta-blockers;
D O I
10.1038/sj.jhh.1002079
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
A clear relationship exists between elevated blood pressure ( BP) and various manifestations of cardiovascular disease. Despite the availability of numerous treatment guidelines, hypertension remains inadequately controlled, with only a small proportion of patients achieving target BP levels. Many factors, both patient and physician related, contribute to this poor level of hypertension control. Major determinants include the implementation of inappropriate treatment regimens that do not enable patients to achieve goal and poor patient compliance. For example, it is widely acknowledged that most patients require two or more antihypertensive drugs to achieve BP goal; however, physicians may be reluctant to employ such treatment strategies. The aim of this review is to explore factors that contribute to poor hypertension control rates and how to overcome these, including the rationale for selecting combination therapy, with particular reference to angiotensin II receptor blocker combinations.
引用
收藏
页码:841 / 849
页数:9
相关论文
共 83 条
[1]   Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis - A randomized controlled trial [J].
Agodoa, LY ;
Appel, L ;
Bakris, GL ;
Beck, G ;
Bourgoignie, J ;
Briggs, JP ;
Charleston, J ;
Cheek, D ;
Cleveland, W ;
Douglas, JG ;
Douglas, M ;
Dowie, D ;
Faulkner, M ;
Gabriel, A ;
Gassman, J ;
Greene, T ;
Hall, Y ;
Hebert, L ;
Hiremath, L ;
Jamerson, K ;
Johnson, CJ ;
Kopple, J ;
Kusek, J ;
Lash, J ;
Lea, J ;
Lewis, JB ;
Lipkowitz, M ;
Massry, S ;
Middleton, J ;
Miller, ER ;
Norris, K ;
O'Connor, D ;
Ojo, A ;
Phillips, RA ;
Pogue, V ;
Rahman, M ;
Randall, OS ;
Rostand, S ;
Schulman, G ;
Smith, W ;
Thornley-Brown, D ;
Tisher, CC ;
Toto, RD ;
Wright, JT ;
Xu, SC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (21) :2719-2728
[2]   Adverse effects of the angiotensin-converting enzyme inhibitors [J].
Alderman, CP .
ANNALS OF PHARMACOTHERAPY, 1996, 30 (01) :55-61
[3]  
[Anonymous], 2002, RED RISKS PROM HLTH
[4]   The importance of blood pressure control in the patient with diabetes [J].
Bakris, GL .
AMERICAN JOURNAL OF MEDICINE, 2004, 116 :30-38
[5]   Control of high blood pressure in primary health care [J].
Banegas, JR .
AMERICAN JOURNAL OF HYPERTENSION, 2006, 19 (02) :146-146
[6]   Valsartan, a new angiotensin II receptor antagonist: A double-blind study comparing the incidence of cough with lisinopril and hydrochlorothiazide [J].
Benz, J ;
Oshrain, C ;
Henry, D ;
Avery, C ;
Chiang, YT ;
Gatlin, M .
JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 37 (02) :101-107
[7]   Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy [J].
Brenner, BM ;
Cooper, ME ;
de Zeeuw, D ;
Keane, WF ;
Mitch, WE ;
Parving, HH ;
Remuzzi, G ;
Snapinn, SM ;
Zhang, ZX ;
Shahinfar, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :861-869
[8]   Angiotensin II receptor antagonists [J].
Burnier, M ;
Brunner, HR .
LANCET, 2000, 355 (9204) :637-645
[9]  
Cardinal H, 2004, CAN J CARDIOL, V20, P417
[10]   Atenolol in hypertension: is it a wise choice? [J].
Carlberg, B ;
Samuelsson, O ;
Lindholm, LJ .
LANCET, 2004, 364 (9446) :1684-1689